News & Updates

High blood pressure (BP) levels do not appear to be an important risk factor for prostate cancer development and death, a study reports.

In the treatment of patients with drug-resistant focal epilepsy, transdermally administered cannabidiol is well tolerated but is not superior to placebo in terms of reducing seizure frequency, according to a study.

Safety analysis of the phase III MAESTRO-NAFLD-1 trial presented at ILC 2022 demonstrated the potential of resmetirom as a treatment for patients with non-alcoholic steatohepatitis (NASH) who have liver fibrosis.

For patients with depression who struggle to fall asleep, electroacupuncture can help with getting a better night’s sleep, with sustained effects, as shown in a study.

Adults with good cardiorespiratory fitness, estimated by a nonexercise algorithm, have a lower risk of developing hypertension, suggests a study.

In the final analysis of the phase III ICON8* study, a weekly dose-dense chemotherapy (CT) regimen comprising paclitaxel and carboplatin did not improve survival outcomes in women with epithelial ovarian cancer** compared with the standard first-line (1L) paclitaxel-carboplatin regimen given once every 3 weeks (Q3W).